Healthcare brands are increasingly under pressure to provide up-to-date, credible medical data to improve or support their pharmaceutical products throughout their lifecycle. The Orbital Research Real World Evidence methodology is backed by the Association of The British Pharmaceutical Industry (ABPI). It has also been reported in:
We love hearing about projects of all sizes. Sign up for a follow up call below and one of the team will be in touch to organise a discovery session to understand your requirements.
“Orbital Research are recognised as the number one world-leading experts in Digital Real World Evidence”
- AESGP Conference
Real-World Evidence (RWE) has drawn a lot of attention recently as an invaluable source of information for clinical practise, health policy, and decision-making related to healthcare. To gain insights into treatment patterns, results, safety, and the cost-effectiveness of interventions in standard...
23 August 2023
Eleanor Easton
The gold standard for assessing the efficacy and safety of medical interventions is randomised controlled trials, or RCTs. They do, however, have inherent constraints that might affect how applicable they are in actual clinical settings. Real-world evidence (RWE) has become a significant source of...
23 August 2023
Eleanor Easton
Randomised clinical trials (RCTs) have always been the gold standard for producing evidence in healthcare research. However, there is growing interest in Real-World...
23 August 2023
Eleanor Easton